Senior researcher Dr Ali Ahmed (University of Alabama, Birmingham) told heartwire that the differing conclusions are the result of two different methodologies used to analyze the data. He said their ...

Most of the estimated 400 000 Canadians who experience heart failure are 65 years of age or older. Heart failure is the most frequent reason for hospital admission for older adults. Admission for ...

February 27, 2004-- The beta-blocker carvedilol in combination with digoxin seems "generally superior" to either carvedilol or digoxin alone and should be considered "the standard treatment" for heart ...

In patients with heart failure with reduced ejection fraction (HFrEF) who have an implantable cardioverter-defibrillator (ICD), the use of digoxin may increase the risk of ventricular tachyarrhythmia ...

A drug commonly used to treat heart conditions, Digoxin, was associated with a 72 percent higher rate of death among adults with newly diagnosed systolic heart failure. This is according to a Kaiser ...

Digoxin (Dixin) is a purified cardiac glycoside derived from leaves of digitalis plant, prescribed for congestive heart failure.It helps the heart work better, which controls the heart rate. The ...

Digoxin 0.25mg/mL; soln for IV or IM inj. Lanoxin (digoxin) Injection, 500 mcg (0.5 mg) in 2 mL (250 mcg [0.25 mg] per mL); box of 10 ampules or 10 vials. Lanoxin (digoxin) Injection Pediatric, 100 ...

To the Editor: The report by Rathore et al. (Oct. 31 issue) 1 emphasizes differences according to sex in the outcomes of digoxin therapy in patients with congestive heart failure. Their post hoc ...

Digoxin was shown to be dangerous at high levels for atrial fibrillation (Afib) patients in a randomized trial. Meanwhile, another study suggested the benefit of genotyping for better warfarin ...

In recent years, the issue of potential drug-drug interactions (DDI) occurring when pharmaceuticals are co-administered has become a subject of increasing recognition. The high frequency of DDIs is ...